Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Transgene initiates phase I trial of malignant melanoma product

June 25, 1999

ImmunoGen receives second milestone payment for anticancer prodrug from SmithKline Beecham

June 22, 1999

Corixa teams up with Japan Tobacco on lung cancer vaccine research

June 21, 1999

Seven preclinical studies demonstrate antitumor activity of NovoMAb-G2

June 16, 1999

Campath-1H trial results presented in Barcelona

June 15, 1999

Follow-up data presented for Bexxar cancer therapy

June 15, 1999

Theragyn improves long-term survival in ovarian cancer patients

June 14, 1999

Data from phase I/II study of NBI-3001 presented at German Society of Neurosurgery

June 11, 1999

Dendreon moves ahead with dendritic cell therapies for cancer

June 10, 1999

Maxamine plus IL-2 prolongs duration of complete remission in patients with AML

June 10, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...